For example, in glioma stem cells, CTSK is responsible for the cleavage and inactivation of stromal-derived factor-1a, and this inactivation promotes stemness loss and increased sensitivity to chemoradiotherapy in glioma stem cells [71]. The gene discussed is CTSK; the disease is central nervous system cancer.